vs
Side-by-side financial comparison of FinVolution Group (FINV) and Guardian Pharmacy Services, Inc. (GRDN). Click either name above to swap in a different company.
FinVolution Group is the larger business by last-quarter revenue ($479.7M vs $336.6M, roughly 1.4× Guardian Pharmacy Services, Inc.). FinVolution Group runs the higher net margin — 21.2% vs 4.0%, a 17.2% gap on every dollar of revenue.
Volution Group plc is a manufacturer of ventilation equipment for commercial and residential customers. Based in Crawley, West Sussex, the company is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index.
CVS Pharmacy Inc. is an American retail corporation. A subsidiary of CVS Health, it is headquartered in Woonsocket, Rhode Island. Originally named the Consumer Value Stores, it was founded in Lowell, Massachusetts, in 1963.
FINV vs GRDN — Head-to-Head
Income Statement — Q1 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $479.7M | $336.6M |
| Net Profit | $101.7M | $13.5M |
| Gross Margin | — | 22.7% |
| Operating Margin | 44.6% | 5.3% |
| Net Margin | 21.2% | 4.0% |
| Revenue YoY | — | 2.2% |
| Net Profit YoY | — | 46.1% |
| EPS (diluted) | — | $0.21 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $336.6M | ||
| Q4 25 | — | $397.6M | ||
| Q3 25 | — | $377.4M | ||
| Q2 25 | — | $344.3M | ||
| Q1 25 | $479.7M | $329.3M | ||
| Q3 24 | — | $314.4M |
| Q1 26 | — | $13.5M | ||
| Q4 25 | — | $20.9M | ||
| Q3 25 | — | $9.8M | ||
| Q2 25 | — | $9.0M | ||
| Q1 25 | $101.7M | $9.4M | ||
| Q3 24 | — | $-122.0M |
| Q1 26 | — | 22.7% | ||
| Q4 25 | — | 21.5% | ||
| Q3 25 | — | 19.8% | ||
| Q2 25 | — | 19.8% | ||
| Q1 25 | — | 19.5% | ||
| Q3 24 | — | 19.4% |
| Q1 26 | — | 5.3% | ||
| Q4 25 | — | 7.7% | ||
| Q3 25 | — | 4.3% | ||
| Q2 25 | — | 3.7% | ||
| Q1 25 | 44.6% | 3.9% | ||
| Q3 24 | — | -33.3% |
| Q1 26 | — | 4.0% | ||
| Q4 25 | — | 5.3% | ||
| Q3 25 | — | 2.6% | ||
| Q2 25 | — | 2.6% | ||
| Q1 25 | 21.2% | 2.9% | ||
| Q3 24 | — | -38.8% |
| Q1 26 | — | $0.21 | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $745.0M | $64.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | — | $232.4M |
| Total Assets | $3.4B | $426.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $64.9M | ||
| Q4 25 | — | $65.6M | ||
| Q3 25 | — | $36.5M | ||
| Q2 25 | — | $18.8M | ||
| Q1 25 | $745.0M | $14.0M | ||
| Q3 24 | — | $37.2M |
| Q1 26 | — | — | ||
| Q4 25 | — | $0 | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | $34.3M |
| Q1 26 | — | $232.4M | ||
| Q4 25 | — | $217.9M | ||
| Q3 25 | — | $195.5M | ||
| Q2 25 | — | $179.7M | ||
| Q1 25 | — | $163.2M | ||
| Q3 24 | — | $133.9M |
| Q1 26 | — | $426.9M | ||
| Q4 25 | — | $412.7M | ||
| Q3 25 | — | $390.0M | ||
| Q2 25 | — | $356.3M | ||
| Q1 25 | $3.4B | $334.0M | ||
| Q3 24 | — | $348.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.00× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | 0.26× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $72.0M | $6.1M |
| Free Cash FlowOCF − Capex | $70.6M | — |
| FCF MarginFCF / Revenue | 14.7% | — |
| Capex IntensityCapex / Revenue | 0.3% | — |
| Cash ConversionOCF / Net Profit | 0.71× | 0.45× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $6.1M | ||
| Q4 25 | — | $34.6M | ||
| Q3 25 | — | $28.2M | ||
| Q2 25 | — | $19.9M | ||
| Q1 25 | $72.0M | $17.6M | ||
| Q3 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | $24.2M | ||
| Q2 25 | — | — | ||
| Q1 25 | $70.6M | — | ||
| Q3 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 6.4% | ||
| Q2 25 | — | — | ||
| Q1 25 | 14.7% | — | ||
| Q3 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 1.1% | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.3% | — | ||
| Q3 24 | — | — |
| Q1 26 | — | 0.45× | ||
| Q4 25 | — | 1.65× | ||
| Q3 25 | — | 2.87× | ||
| Q2 25 | — | 2.21× | ||
| Q1 25 | 0.71× | 1.86× | ||
| Q3 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
